CLDN18

CLDN18
Identifiers
AliasesCLDN18, SFTA5, SFTPJ, claudin 18
External IDsOMIM: 609210; MGI: 1929209; GeneCards: CLDN18
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_016369
NM_001002026

NM_001194921
NM_001194922
NM_001194923
NM_019815

RefSeq (protein)

NP_001002026
NP_057453

NP_001181850
NP_001181851
NP_001181852
NP_062789

Location (UCSC)Chr 3: 138 – 138.03 MbChr 9: 99.57 – 99.6 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Claudin-18 is a protein that in humans is encoded by the CLDN18 gene.[5] It belongs to the group of claudins.

CLDN18 belongs to the large claudin family of proteins, which form tight junction strands in epithelial cells .[6] [supplied by OMIM][5]

Clinical significance

Isoform 2 (Claudin 18.2) is abundant in gastric tumors.[7]

Zolbetuximab targets Claudin 18.2 to help treat gastric and gastroesophageal junction cancers.[8][9] [10]

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000066405Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000032473Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ a b "Entrez Gene: CLDN18 claudin 18".
  6. ^ Niimi T, Nagashima K, Ward JM, et al. (2001). "claudin-18, a Novel Downstream Target Gene for the T/EBP/NKX2.1 Homeodomain Transcription Factor, Encodes Lung- and Stomach-Specific Isoforms through Alternative Splicing". Mol. Cell. Biol. 21 (21): 7380–90. doi:10.1128/MCB.21.21.7380-7390.2001. PMC 99911. PMID 11585919.
  7. ^ Antibody Shines in Advanced Gastric Cancer - IMAB362 leads to longer remission, better survival. June 2016
  8. ^ "Astellas' VYLOY™ (zolbetuximab) Approved in Japan for Treatment of Gastric Cancer a". www.prnewswire.com. 2024-03-26. Retrieved 2024-09-29.
  9. ^ Ouladan S, Orouji E (March 2025). "CAR-T Cells in Colorectal Cancer: Pioneering New Avenues in Solid Tumor Immunotherapy". Journal of Clinical Oncology. 42 (23): 2637–2639. doi:10.1200/JCO.24.02081. PMC 11895826. PMID 39805063.
  10. ^ Liu, Jian; Yang, Jing; Sun, Ying (July 2025). "CLDN18.2–targeting antibody–drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trial". Nature Medicine. na (na): s41591-025-03783-8. doi:10.1038/s41591-025-03783-8. PMC 12443601. PMID 40670773.

Further reading

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.